Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
4
×
life sciences
national blog main
amgen
eli lilly
migraine
abbvie
akouos
allergan
astellas pharmaceuticals
bempedoic acid
biohaven
boston
boston blog main
calcitonin gene-related peptide
california institute for biomedical research
cgpr
cholesterol
chronic migraine
corticosteroids
deals
decibel therapeutics
detroit
detroit blog main
detroit top stories
drugs
episodic migraine
esperion therapeutics
europe blog main
ezetimibe
fluoroquinolones
frequency therapeutics
harvard university
hearing loss
indiana
indiana blog main
indiana top stories
investing
What
approved
4
×
fda
medicines
4
×
drug
class
migraine
new
nod
pill
therapeutics
treat
wins
adults
affects
allergan
americans
announced
approval
cholesterol
combo
date
decision
developed
developing
eli
esperion
esperion’s
frequency
headache
hearing
ipo
late
levels
lilly
loss
lowering
marks
meds
millions
monday
Language
unset
Current search:
medicines
×
fda
×
approved
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
